Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes

Authors:

Levy AR, Zou D, Risebrough N, Buckstein R, Kim T and Brereton N.

Publication Type:

Journal Article

Publication Name:

Current oncology

Citation:

Levy AR, Zou D, Risebrough N, Buckstein R, Kim T and Brereton N. Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes. Curr Oncol. 2014;21(1):e29-40.


Link to publication ⟶

⟵ Back to Search Results